Corporate
Positive
Smith+Nephew comparative study1 shows PICO◊ sNPWT (-80 mmHg) delivers superior performance in relation to wound dehiscence and reduces healthcare costs across cardiovascular and orthopedic surgery versus PrevenaTM -125 mmHg sNPWT
Breaking news from global financial markets
1 week ago
Read More
1 week ago
3,506
1 week ago
3,274
1 week ago
3,822
1 week ago
1,766
Share buy-back program
Corporate
1 week ago
3,667
1 week ago
1,071
1 week ago
3,109
Share buyback programme - week 43
Corporate
1 week ago
2,986
Share buyback programme - week 43
Corporate
1 week ago
4,624
1 week ago
1,599
1 week ago
3,895
1 week ago
2,448
1 week ago
1,769
1 week ago
2,898
1 week ago
1,960
Trending Now
1
127-year-old jewelry chain closing forever, no bankruptcy
33,537
53 minutes ago
2
TNDM Investor News: If You Have Suffered Losses in Tandem Diabetes Care, Inc. (N...
13,288
53 minutes ago
3
3 Must-Own Stocks for the Driverless Vehicle Revolution
13,744
1 hour ago
4
5
10 Defensive Stocks with Market-Beating Yields
34,511
1 hour ago